Clinical Trial Update: Decitabine in Treating Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

This update reports the completion of a Phase 1 trial of decitabine in patients with advanced solid tumors, including breast, bladder, and melanoma cancers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Breast Cancer
• Melanoma

Drugs mentioned

• Decitabine (Decitabine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Male Breast Cancer, Recurrent Bladder Cancer | Phase 1 | Status: COMPLETED